Activation of the cGAS-STING pathway can promote the maturation of antigen-presenting cells (APCs), induce the generation of cytokines and the production of CD8+ T cells against tumor antigens [36], and, at last, reshape the tumor microenvironment and enhance the anti-tumor immune response. The gene discussed is STING1; the disease is neoplasm.